| Identification |
| Name: | 3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-hydroxy-1-methylpropyl)- |
| Synonyms: | Hydroxyitraconazole;R 63373 |
| CAS: | 112559-91-8 |
| Molecular Formula: | C35H38 Cl2 N8 O5 |
| Molecular Weight: | 707.65 |
| InChI: | InChI=1/C35H38Cl2N8O5/c1-24(25(2)46)45-34(47)44(23-40-45)29-6-4-27(5-7-29)41-13-15-42(16-14-41)28-8-10-30(11-9-28)48-18-31-19-49-35(50-31,20-43-22-38-21-39-43)32-12-3-26(36)17-33(32)37/h3-12,17,21-25,31,46H,13-16,18-20H2,1-2H3/t24?,25?,31-,35-/m0/s1 |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 488.8°C |
| Boiling Point: | 884.7°Cat760mmHg |
| Density: | 1.44g/cm3 |
| Refractive index: | 1.687 |
| Flash Point: | 488.8°C |
| Usage: | A metabolite of Itraconazole, an orally active antimycotic structurally related to Ketoconazole |
| Safety Data |
| |
 |
